Anwar H, Strap JL, Chen K, Costerton JW. 1992. Dynamic interactions of biofilms of mucoid Pseudomonas -aeruginosa with tobramycin and piperacillin. . Antimicrobial Agents and Chemotherapy 36:1208–1214.

Hoiby N, Ciofu O, Bjarnsholt T. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiology 5:1663.

Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, Mcgregor JC. 2007. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection. Antimicrobial Agents and Chemotherapy 51:3510–3515.

O'toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary forPseudomonas aeruginosabiofilm development. Molecular Microbiology 30:295–304.

Biofilm basics: Section 1 | Center for Biofilm Engineering. Center for BiofilmEngineering.

Biofilm basics: Section 4 | Center for Biofilm Engineering. Center for Biofilm Engineering

Donlan RM. 2002. Biofilms: Microbial Life on Surfaces. Emerging Infectious Diseases8:881–890.

Unosson E. 2015. Antibacterial Strategies for Titanium Biomaterials (PDF)